Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Geisinger Medical Center
mi
from
Danville, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Doylestown Hospital
mi
from
Doylestown, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Doylestown Hospital
mi
from
Doylestown, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Harrisburg Hospital / Pinnacle Health
mi
from
Harrisburg, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Harrisburg Hospital / Pinnacle Health
mi
from
Harrisburg, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Lancaster Heart and Stroke Foundation
mi
from
Lancaster, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Lancaster Heart and Stroke Foundation
mi
from
Lancaster, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Hahnemann Hospital
mi
from
Philadelphia, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Hahnemann Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Holy Spirit Hospital
mi
from
Wormleysburg, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Holy Spirit Hospital
mi
from
Wormleysburg, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Main Line Health Heart Center/The Lankenau Hospital
mi
from
Wynnewood, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Main Line Health Heart Center/The Lankenau Hospital
mi
from
Wynnewood, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
York Hospital
mi
from
York, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Miriam Hospital
mi
from
Providence, RI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
AnMed Health
mi
from
Anderson, SC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
AnMed Health
mi
from
Anderson, SC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Providence Hospital-SC
mi
from
Columbia, SC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Providence Hospital-SC
mi
from
Columbia, SC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Sanford USD Medical Center
mi
from
Sioux Falls, SD
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Memorial Health System
mi
from
Chattanooga, TN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Memorial Health System
mi
from
Chattanooga, TN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
West Clinic d/b/a Memphis Heart Clinic
mi
from
Memphis, TN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
West Clinic d/b/a Memphis Heart Clinic
mi
from
Memphis, TN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Centennial Heart Cardiovascular Consultants, LLC
mi
from
Nashville, TN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Centennial Heart Cardiovascular Consultants, LLC
mi
from
Nashville, TN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Thomas Hospital
mi
from
Nashville, TN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Thomas Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Vanderbilt Vniversity Medical Center
mi
from
Nashville, TN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Vanderbilt Vniversity Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Amarillo Heart Clinical Research Institute Inc.
mi
from
Amarillo, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Amarillo Heart Clinical Research Institute Inc.
mi
from
Amarillo, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Capital Cadiovascular Specialists
mi
from
Austin, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Capital Cadiovascular Specialists
mi
from
Austin, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Methodist Hospital
mi
from
Houston, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Lubbock Heart Hospital
mi
from
Lubbock, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Lubbock Heart Hospital
mi
from
Lubbock, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Permian Research Foundation
mi
from
Odessa, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Permian Research Foundation
mi
from
Odessa, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
South Texas Methodist Hospital
mi
from
San Antonio, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
South Texas Methodist Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Intermountain Medical Center
mi
from
Salt Lake City, UT
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Intermountain Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
University of Virginia Health System
mi
from
Charlottesville, VA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Virginia Cardiovascular Consultants
mi
from
Fredericksburg, VA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Virginia Cardiovascular Consultants
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Carilion Roanoke Memorial
mi
from
Roanoke, VA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Carilion Roanoke Memorial
mi
from
Roanoke, VA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Overlake Hospital Medical Center
mi
from
Bellevue, WA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Overlake Hospital Medical Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Providence Everett Medical Center
mi
from
Everett, WA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Providence Everett Medical Center
mi
from
Everett, WA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Joseph's Tacoma
mi
from
Tacoma, WA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Joseph's Tacoma
mi
from
Tacoma, WA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St Mary's Medical Hospital
mi
from
Huntington, WV
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St Mary's Medical Hospital
mi
from
Huntington, WV
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
The Wisconsin Heart Hospital
mi
from
Wauwatosa, WI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
The Wisconsin Heart Hospital
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Does DHEA Improve Endothelial Dysfunction and Other Cardiovascular Risk Factors in Premenopausal Women With Systemic Lupus?
Status: Enrolling
Updated:  5/17/2016
University of Michigan
mi
from
Ann Arbor, MI
Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Does DHEA Improve Endothelial Dysfunction and Other Cardiovascular Risk Factors in Premenopausal Women With Systemic Lupus?
Status: Enrolling
Updated: 5/17/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Better Adherence to Therapeutic Lifestyle Change Efforts Trial
Better Adherence to Therapeutic Lifestyle Change Efforts (BATTLE) Trial
Status: Enrolling
Updated:  5/17/2016
Walter Reed National Military Medical Center / Integrative Cardiac Health Project (ICHP)
mi
from
Bethesda, MD
Better Adherence to Therapeutic Lifestyle Change Efforts Trial
Better Adherence to Therapeutic Lifestyle Change Efforts (BATTLE) Trial
Status: Enrolling
Updated: 5/17/2016
Walter Reed National Military Medical Center / Integrative Cardiac Health Project (ICHP)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Seton Hill University--Personal Empowerment Program
Seton Hill University--Personal Empowerment Program
Status: Enrolling
Updated:  5/17/2016
Integrative Cardiac Health Project, Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Seton Hill University--Personal Empowerment Program
Seton Hill University--Personal Empowerment Program
Status: Enrolling
Updated: 5/17/2016
Integrative Cardiac Health Project, Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Seton Hill University--Personal Empowerment Program
Seton Hill University--Personal Empowerment Program
Status: Enrolling
Updated:  5/17/2016
Seton Hill University
mi
from
Greensburg, PA
Seton Hill University--Personal Empowerment Program
Seton Hill University--Personal Empowerment Program
Status: Enrolling
Updated: 5/17/2016
Seton Hill University
mi
from
Greensburg, PA
Click here to add this to my saved trials
CO as a Stimulant for Mitochondrial Biogenesis in Human Cardiac Muscle
Effects of Low Level Carbon Monoxide Preconditioning on Human Mitochondrial Biogenesis in Aortic Valve Surgery Patients
Status: Enrolling
Updated:  5/18/2016
Duke Hospital
mi
from
Durham, NC
CO as a Stimulant for Mitochondrial Biogenesis in Human Cardiac Muscle
Effects of Low Level Carbon Monoxide Preconditioning on Human Mitochondrial Biogenesis in Aortic Valve Surgery Patients
Status: Enrolling
Updated: 5/18/2016
Duke Hospital
mi
from
Durham, NC
Click here to add this to my saved trials
RNA Cloning and Visualization in Human Atherosclerosis
RNA Cloning and Visualization in Human Atherosclerosis
Status: Enrolling
Updated:  5/23/2016
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
RNA Cloning and Visualization in Human Atherosclerosis
RNA Cloning and Visualization in Human Atherosclerosis
Status: Enrolling
Updated: 5/23/2016
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated:  5/23/2016
Park Nicollet- Brookdale
mi
from
Brooklyn Center, MN
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated: 5/23/2016
Park Nicollet- Brookdale
mi
from
Brooklyn Center, MN
Click here to add this to my saved trials
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated:  5/23/2016
Ridgeview Medical Center
mi
from
Delano, MN
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated: 5/23/2016
Ridgeview Medical Center
mi
from
Delano, MN
Click here to add this to my saved trials
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated:  5/23/2016
Essentia Health-Lakeside Clinic
mi
from
Duluth, MN
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated: 5/23/2016
Essentia Health-Lakeside Clinic
mi
from
Duluth, MN
Click here to add this to my saved trials
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated:  5/23/2016
Fairview Clinic-Eagan
mi
from
Eagan, MN
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated: 5/23/2016
Fairview Clinic-Eagan
mi
from
Eagan, MN
Click here to add this to my saved trials
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated:  5/23/2016
Park Nicollet-Golden Valley
mi
from
Golden Valley, MN
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated: 5/23/2016
Park Nicollet-Golden Valley
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated:  5/23/2016
Essentia Hermantown Clinic
mi
from
Hermantown, MN
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated: 5/23/2016
Essentia Hermantown Clinic
mi
from
Hermantown, MN
Click here to add this to my saved trials
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated:  5/23/2016
Native American Community Clinic
mi
from
Minneapolis, MN
Use of Decision Aids in Clinical Encounters
Patient-centered Dissemination of Evidence-based Medicine: Share EBM
Status: Enrolling
Updated: 5/23/2016
Native American Community Clinic
mi
from
Minneapolis, MN
Click here to add this to my saved trials